poisar

Stocks · News reference

Novo Nordisk Receives European Commission's Marketing Authorization For Wegovy Pill To Treat Adults With Obesity

BenzingaJul 15, 2026, 3:57 PMBenzinga Newsdesk

Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Wegovy® pill (once-daily oral semaglutide 25 mg) for the treatment of adults with obesity (BMI ≥30 kg/m²) or

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 15, 2026, 3:57 PM
Checked
Jul 15, 2026, 3:57 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading